The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug August 24, 2017 AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round October 22, 2017 Cambridge's Surface Oncology Promotes CBO to Top Job February 11, 2018